Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deirdre Gillespie Insider Profile
4 Followers
Deirdre Gillespie, Director at Seelos Therapeutics, holds 15.43K shares in Seelos Therapeutics (Ticker: SEEL), holds 0.00 shares in La Jolla Pharma (Ticker: LJPC).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+98.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Deirdre Gillespie holds in companies
Most Profitable Insider Trade
The most profitable trade made by Deirdre Gillespie
Deirdre Gillespie's Trading History
Seelos Therapeutics
Jan 04, 2012
Director
Uninformative Buy
14.28K
$15.90K
La Jolla Pharma
May 18, 2011
President & CEO, Director
Uninformative Buy
―
$0.00
List of latest transactions for each holding click on a transaction to see Deirdre Gillespie's performance on stock
You May Also Like
Deirdre Gillespie insider profile FAQ
What is the percentage of profitable transactions made by Deirdre Gillespie?
The percentage of profitable transactions made by Deirdre Gillespie is 100%.
What is the average return per transaction made by Deirdre Gillespie?
The average return per transaction made by Deirdre Gillespie is 98.00%.
What stocks does Deirdre Gillespie hold?
Deirdre Gillespie holds: SEEL, LJPC stocks.
What was Deirdre Gillespie’s latest transaction?
Deirdre Gillespie latest transaction was an Uninformative Buy of $14.28K.
What was Deirdre Gillespie's most profitable transaction?
Deirdre Gillespie’s most profitable transaction was an Informative Sell of LJPC stock on April 20, 2011. The return on the trade was 99.90%.
What is Deirdre Gillespie's role in Seelos Therapeutics?
Deirdre Gillespie's role in Seelos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.